Company Description
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe.
It operates through two segments, Waters and TA.
The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research.
Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Country | United States |
IPO Date | Nov 17, 1995 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 7,900 |
CEO | Dr. Udit Batra Ph.D. |
Contact Details
Address: 34 Maple Street Milford, Massachusetts United States | |
Website | https://www.waters.com |
Stock Details
Ticker Symbol | WAT |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001000697 |
CUSIP Number | 941848103 |
ISIN Number | US9418481035 |
Employer ID | 13-3668640 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Dr. Udit Batra Ph.D. | President, Chief Executive Officer & Director |
Amol Chaubal | Senior Vice President & Chief Financial Officer |
Caspar Tudor | Director of Investor Relations |
Christos Ross | Senior Vice President of Global Operations |
Dr. Daniel Rush Ph.D. | Senior Vice President of Strategy & Transformation |
Jianqing Y. Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit |
Keeley A. Aleman J.D. | Senior Vice President, General Counsel & Corporate Secretary |
Kristen Garvey | Vice President of Corporate Communications |
Patrick Conway | Interim Vice President of Human Resources |
Robert L. Carpio III | Senior Vice President of Waters Division |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 01, 2024 | 8-K/A | [Amend] Current Report |
Nov 01, 2024 | 10-Q | Quarterly Report |
Nov 01, 2024 | 8-K | Current Report |
Oct 25, 2024 | 4/A | [Amend] Filing |
Oct 02, 2024 | 4 | Filing |
Oct 02, 2024 | 4 | Filing |
Oct 02, 2024 | 4 | Filing |
Aug 15, 2024 | 4 | Filing |